Biochemical and electrophysiological studies on the mechanism of action of PNU-151774E, a novel antiepileptic compound.
暂无分享,去创建一个
R. Maj | C. Caccia | P. Pevarello | M. Varasi | M. Mazzanti | R. Fariello | H. White | H. Wolf | E. Mancinelli | G. Skeen | M. A. Cervini | P. Salvati | M. G. Fornaretto | E. Lamberti | L. Faravelli
[1] R. Maj,et al. PNU-151774E protects against kainate-induced status epilepticus and hippocampal lesions in the rat. , 1998, European journal of pharmacology.
[2] R. Maj,et al. Preclinical evaluation of PNU-151774E as a novel anticonvulsant. , 1998, The Journal of pharmacology and experimental therapeutics.
[3] P. Pevarello,et al. Synthesis and anticonvulsant activity of a new class of 2-[(arylalky)amino]alkanamide derivatives. , 1998, Journal of medicinal chemistry.
[4] C. Zona,et al. Lamotrigine Reduces Voltage‐Gated Sodium Currents in Rat Central Neurons in Culture , 1997, Epilepsia.
[5] J. Ferrendelli,et al. Voltage-dependent calcium channels as targets for convulsant and anticonvulsant alkyl-substituted thiobutyrolactones. , 1997, The Journal of pharmacology and experimental therapeutics.
[6] B. Meldrum. Update on the Mechanism of Action of Antiepileptic Drugs , 1996, Epilepsia.
[7] C. Taylor. Voltage-gated Na+ Channels as Targets for Anticonvulsant, Analgesic and Neuroprotective Drugs , 1996, Current Pharmaceutical Design.
[8] W. Löscher,et al. Anticonvulsant and antiepileptogenic effect of L-deprenyl (selegiline) in the kindling model of epilepsy. , 1995, The Journal of pharmacology and experimental therapeutics.
[9] D. Choi. Calcium: still center-stage in hypoxic-ischemic neuronal death , 1995, Trends in Neurosciences.
[10] F. Oesch,et al. The Anticonvulsant FCE 26743 is a Selective and Short‐acting MAO‐B Inhibitor Devoid of Inducing Properties towards Cytochrome P450‐dependent Testosterone Hydroxylation in Mice and Rats , 1994, The Journal of pharmacy and pharmacology.
[11] M. Dichter. Emerging Insights Into Mechanisms of Epilepsy: Implications for New Antiepileptic Drug Development , 1994, Epilepsia.
[12] B. Cooper,et al. Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells. , 1993, The Journal of pharmacology and experimental therapeutics.
[13] E. Nemeth,et al. Modulation of N-methyl-d-aspartate receptor-mediated increases in cytosolic calcium in cultured rat cerebellar granule cells , 1991, Brain Research.
[14] M. Dichter,et al. Electrophysiological comparison of pyramidal and stellate nonpyramidal neurons in dissociated cell culture of rat hippocampus , 1991, Brain Research Bulletin.
[15] M A Rogawski,et al. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. , 1990, Pharmacological reviews.
[16] L. Willmore. Post‐Traumatic Epilepsy: Cellular Mechanisms and Implications for Treatment , 1990, Epilepsia.
[17] D. N. Pathak,et al. Lipid Peroxidation and Glutathione Peroxidase, Glutathione Reductase, Superoxide Dismutase, Catalase, and Glucose‐6‐Phosphate Dehydrogenase Activities in FeCl3‐Induced Epileptogenic Foci in the Rat Brain , 1990, Epilepsia.
[18] T. Narahashi,et al. Mechanisms of calcium channel block by phenytoin. , 1988, The Journal of pharmacology and experimental therapeutics.
[19] A. Wyler,et al. Levels of Catechols in Epileptogenic and Nonepileptogenic Regions of the Human Brain , 1988, Journal of neurochemistry.
[20] M. Leach,et al. Pharmacological Studies on Lamotrigine, A Novel Potential Antiepileptic Drug , 1986, Epilepsia.
[21] W. Triggs,et al. The role of iron-induced hippocampal peroxidation in acute epileptogenesis , 1986, Brain Research.
[22] A. Cm,et al. Two distinct populations of calcium channels in a clonal line of pituitary cells. , 1985 .
[23] W. Triggs,et al. In Vivo Lipid Peroxidation in Rat Brain Following Intracortical Fe2+ Injection , 1984, Journal of neurochemistry.
[24] R. Macdonald,et al. Multiple actions of phenytoin on mouse spinal cord neurons in cell culture. , 1983, The Journal of pharmacology and experimental therapeutics.
[25] D Rodbard,et al. Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.
[26] I. Lampl,et al. Reduction of cortical pyramidal neuron excitability by the action of phenytoin on persistent Na+ current. , 1998, The Journal of pharmacology and experimental therapeutics.
[27] R. Maj,et al. Anticonvulsant activity of FCE 26743 in the kindling model of epilepsy , 1995 .
[28] R. Macdonald. Antiepileptic drug mechanism of action , 1995 .
[29] P. Jobe,et al. Anticonvulsant effects of intracerebroventricularly administered norepinephrine are potentiated in the presence of monoamine oxidase inhibition in severe seizure genetically epilepsy-prone rats (GEPR-9s). , 1993, Life sciences.
[30] G. Skeen,et al. Pharmacological regulation of astrocytic calcium channels: implications for the treatment of seizure disorders. , 1992, Progress in brain research.
[31] White Hs,et al. Pharmacological regulation of astrocytic calcium channels: implications for the treatment of seizure disorders. , 1992 .
[32] A. Wyler,et al. Levels of biogenic amines, their metabolites, and tyrosine hydroxylase activity in the human epileptic temporal cortex , 1990, Synapse.
[33] B. Yamamoto,et al. An improved and rapid HPLC-EC method for the isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates. , 1988, Life sciences.
[34] C. Armstrong,et al. Two distinct populations of calcium channels in a clonal line of pituitary cells. , 1985, Science.
[35] D. Woodbury. Phenytoin: proposed mechanisms of anticonvulsant action. , 1980, Advances in neurology.
[36] Woodbury Dm. Phenytoin: proposed mechanisms of anticonvulsant action. , 1980 .